Results 311 to 320 of about 83,758 (359)
Some of the next articles are maybe not open access.
To aPTT or not to aPTT: Evaluating the optimal monitoring strategy for unfractionated heparin
Thrombosis Research, 2022Nathan T, Connell, Katelyn W, Sylvester
openaire +2 more sources
The activated partial thromboplastin time (APTT)
1992The term partial thromboplastin is used to distinguish the reagent from that used in the prothrombin time, since the APTT reagent lacks the apoprotein component of the complete tissue thromboplastin. The APTT is the main test for screening for intrinsic clotting defects including haemophilia. It is also used for detection of lupus anticoagulant and for
L. Poller, J. M. Thomson
openaire +1 more source
APTT in patients on LMWH prophylaxis
Clinical chemistry and laboratory medicine. Special supplement, 2001APTT in patients on LMWH ...
Bronić, Ana +2 more
openaire
Should we abandon the APTT for monitoring unfractionated heparin?
Thrombosis Research, 2017D. Arachchillage +4 more
semanticscholar +1 more source
International journal of hematology, 2017
Tomoko Matsumoto, K. Nogami, M. Shima
semanticscholar +1 more source
Tomoko Matsumoto, K. Nogami, M. Shima
semanticscholar +1 more source
Prolongation of Both PT and aPTT
2013The global coagulation tests, prothrombin time (PT) and activated partial thromboplastin time (aPTT), are commonly used to screen for coagulation deficiencies and are usually done in preparation for surgery. Simultaneous prolongation of both times can be found in severe hepatic disease, vitamin K deficiency, and disseminated intravascular coagulation ...
openaire +1 more source